307 related articles for article (PubMed ID: 33064898)
1. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
[TBL] [Abstract][Full Text] [Related]
2. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer.
Chapman CJ; Banerjea A; Humes DJ; Allen J; Oliver S; Ford A; Hardy K; Djedovic N; Logan RF; Morling JR
Clin Chem Lab Med; 2021 Mar; 59(4):721-728. PubMed ID: 33112776
[TBL] [Abstract][Full Text] [Related]
3. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care.
Mowat C; Digby J; Strachan JA; McCann RK; Carey FA; Fraser CG; Steele RJ
Ann Clin Biochem; 2021 May; 58(3):211-219. PubMed ID: 33334134
[TBL] [Abstract][Full Text] [Related]
4. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of repeat faecal immunochemical testing in symptomatic patients attending primary care.
Johnstone MS; MacLeod C; Digby J; Al-Azzawi Y; Pang G; Watson AJM; Strachan J; Mowat C; McSorley ST
Colorectal Dis; 2022 Dec; 24(12):1498-1504. PubMed ID: 35776684
[TBL] [Abstract][Full Text] [Related]
6. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
[TBL] [Abstract][Full Text] [Related]
7. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
[TBL] [Abstract][Full Text] [Related]
8. Combining the quantitative faecal immunochemical test and full blood count reliably rules out colorectal cancer in a symptomatic patient referral pathway.
Johnstone MS; Burton P; Kourounis G; Winter J; Crighton E; Mansouri D; Witherspoon P; Smith K; McSorley ST
Int J Colorectal Dis; 2022 Feb; 37(2):457-466. PubMed ID: 34932152
[TBL] [Abstract][Full Text] [Related]
9. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.
Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB
Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785
[TBL] [Abstract][Full Text] [Related]
10. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study.
Digby J; Strachan JA; Mowat C; Steele RJC; Fraser CG
BMC Gastroenterol; 2019 Dec; 19(1):213. PubMed ID: 31829141
[TBL] [Abstract][Full Text] [Related]
11. Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study.
Hicks G; D'Souza N; Georgiou Delisle T; Chen M; Benton SC; Abulafi M;
Colorectal Dis; 2021 Jul; 23(7):1630-1638. PubMed ID: 33605522
[TBL] [Abstract][Full Text] [Related]
12. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited.
Digby J; Fraser CG; Carey FA; Lang J; Stanners G; Steele RJ
J Med Screen; 2016 Sep; 23(3):130-4. PubMed ID: 26589788
[TBL] [Abstract][Full Text] [Related]
13. Do risk scores improve use of faecal immunochemical testing for haemoglobin in symptomatic patients in primary care?
Digby J; Fraser CG; Clark G; Mowat C; Strachan JA; Steele RJC
Colorectal Dis; 2024 Apr; 26(4):675-683. PubMed ID: 38424669
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems.
Benton SC; Piggott C; Zahoor Z; O'Driscoll S; Fraser CG; D'Souza N; Chen M; Georgiou Delisle T; Abulafi M
Clin Chem Lab Med; 2022 Jul; 60(8):1278-1286. PubMed ID: 35637625
[TBL] [Abstract][Full Text] [Related]
15. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
[TBL] [Abstract][Full Text] [Related]
16. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy.
Senore C; Zappa M; Campari C; Crotta S; Armaroli P; Arrigoni A; Cassoni P; Colla R; Fracchia M; Gili F; Grazzini G; Lolli R; Menozzi P; Orione L; Polizzi S; Rapi S; Riggi E; Rubeca T; Sassatelli R; Visioli C; Segnan N
Gut; 2020 Mar; 69(3):523-530. PubMed ID: 31455608
[TBL] [Abstract][Full Text] [Related]
17. Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality.
Clark GR; Godfrey T; Purdie C; Strachan J; Carey FA; Fraser CG; Steele RJ
J Med Screen; 2024 Mar; 31(1):21-27. PubMed ID: 37469171
[TBL] [Abstract][Full Text] [Related]
18. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
[TBL] [Abstract][Full Text] [Related]
19. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
[TBL] [Abstract][Full Text] [Related]
20. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
Digby J; Fraser CG; Carey FA; Diament RH; Balsitis M; Steele RJ
J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
